(0.09%) 5 474.21 points
(0.10%) 39 153 points
(0.41%) 17 790 points
(-0.22%) $80.65
(-3.66%) $2.66
(-0.78%) $2 312.60
(0.16%) $28.92
(3.46%) $1 020.50
(0.29%) $0.936
(0.71%) $10.68
(0.47%) $0.792
(-0.27%) $87.25
Live Chart Being Loaded With Signals
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States...
Stats | |
---|---|
今日成交量 | 5.38M |
平均成交量 | 787 717 |
市值 | 12.11M |
EPS | $-0.0111 ( Q2 | 2023-08-14 ) |
下一个收益日期 | ( $0 ) 2024-08-12 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.867 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0180 (11.61%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-02 | Fr Capital Holdings, L.p. | Sell | 50 000 | Ordinary Shares, par value NIS 0.35 each |
2023-12-28 | Fr Capital Holdings, L.p. | Sell | 21 500 | Ordinary Shares, par value NIS 0.35 each |
2023-12-29 | Fr Capital Holdings, L.p. | Sell | 6 000 | Ordinary Shares, par value NIS 0.35 each |
2023-12-26 | Fr Capital Holdings, L.p. | Sell | 11 456 | Ordinary Shares, par value NIS 0.35 each |
2023-12-27 | Fr Capital Holdings, L.p. | Sell | 20 033 | Ordinary Shares, par value NIS 0.35 each |
INSIDER POWER |
---|
-43.58 |
Last 32 transactions |
Buy: 525 000 | Sell: 1 196 932 |
音量 相关性
Vascular Biogenics Ltd 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Vascular Biogenics Ltd 相关性 - 货币/商品
Vascular Biogenics Ltd 财务报表
Annual | 2022 |
营收: | $658 000 |
毛利润: | $554 000 (84.19 %) |
EPS: | $-0.420 |
FY | 2022 |
营收: | $658 000 |
毛利润: | $554 000 (84.19 %) |
EPS: | $-0.420 |
FY | 2021 |
营收: | $768 000 |
毛利润: | $403 000 (52.47 %) |
EPS: | $-0.685 |
FY | 2020 |
营收: | $922 000 |
毛利润: | $528 000 (57.27 %) |
EPS: | $-0.550 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Vascular Biogenics Ltd
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antibody-based technology that enables specifically inhibit monocyte migration for immune-inflammatory applications. The company's lead product candidate is VB-111, a gene-based biologic that is in Phase III clinical trials for the recurrent platinum-resistant ovarian cancer; and Phase II clinical trials treatment of recurrent glioblastoma and colorectal cancer, as well as has completed Phase II clinical trial for the treatment of thyroid cancer. It is also developing VB-601 for various inflammatory indications, and VB-611 for various solid tumors. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modi'in, Israel.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。